您好，欢迎来到半岛电竞官方网址 ！ [ 登录] [ 免费注册]
半岛电竞官方网址
发布求购
位置： 首页> 半岛bd体育手机客户端 库> Cantuzumab mertansine
立即咨询
咨询类型：
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
Cantuzumab mertansine
本半岛bd体育手机客户端 不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
CAS NO: 400010-39-1
包装与价格：
包装 价格(元)
1mg 电议
5mg 电议

半岛bd体育手机客户端 名称
莫坎妥珠单抗
SB-408075
huC242-DM1
半岛bd体育手机客户端 介绍
Cantuzumab mertansine (SB-408075; huC242-DM1) 是一种 ADC，是强效美登素衍生物 (DM1; HY-19792) 和针对 CanAg 的人源化单克隆抗体 (huC242) 的免疫偶联物。Cantuzumab mertansine 对结肠癌细胞具有细胞毒性，并且对一系列 CanAg 阳性人肿瘤异种移植物具有广泛的抗肿瘤活性。
生物活性

Cantuzumab mertansine (SB-408075; huC242-DM1), anADC, is an immunoconjugate of the potent maytansine derivative (DM1; HY-19792) and the humanized monoclonal antibody (huC242) directed to CanAg. Cantuzumab mertansine has cytotoxic toward coloncancercells and has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts[1][2].
体外研究
(In Vitro)

Cantuzumab mertansine (SB-408075; huC242-DM1; 0-100 μM; 24 小时) 对抗原阳性 COLO 205 细胞系具有选择性细胞毒活性[1]。

Cell Cytotoxicity Assay[1]

Cell Line: Antigen-positive COLO 205 cell line and the antigen-negative A-375 melanoma cell line
Concentration: 0-100 μM
Incubation Time: 24 h
Result: Had cytotoxic activity on COLO 205 cells with an IC50value of 0.032 nM (23.5 pg/ml).
Had 1100-fold less cytotoxic activity for the antigen-negative A-375 cells (IC50=36 nM; 26.5 ng/ml).
体内研究
(In Vivo)

Cantuzumab mertansine (SB-408075; huC242-DM1; 300 μg/kg/天; 持续 5 天) 使携带 COLO 205 结肠癌人异种移植物的小鼠完全消退和治愈[1]。

Animal Model: Female CB-17 SCID mice, 6-7 weeks of age bearing COLO 205 human colon tumor xenografts[1]
Dosage: 300 μg/kg
Administration: Daily for 5 days
Result: Completely eliminated any measurable tumors within 2 weeks of the initiation of therapy, and all eight animals were tumor-free for 200 days (duration of the experiment).
CAS 号

400010-39-1
中文名称

莫坎妥珠单抗
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Baidu
map